retatrutide fda approval status october 2025 Retatrutide has not been approved by the FDA, but precisely one 79-year-old man was granted access via "compassionate use." Read more: https://www.huffpost.com/entry/trump-experimental-drug-retatrutide_n_6a3aa4c7e4b058c5d1c4bf46?ref

Can GLP 1 agonists improve psoriasis beyond weight loss? In a recent cohort study of patients with obesity and psoriasis, GLP 1 analogues demonstrated higher rates of skin clearance and enhanced response when combined Recent understandings about hypertension management in type 2 diabetes: What are the roles of SGLT2 inhibitor, GLP 1 receptor agonist, and finerenone? Hypertension Research GLP 1 medications have changed the conversation around weight management, but they're not without side effects. The most common concerns include nausea, constipation, fatigue, muscle loss and nutritional inadequaciesmany of which can be We love GLP 1 medications. But they're not the right tool for everyone. Swipe through four reasons a GLP 1 alone might not be enough for your situation. And if you're not sure where Glucagon like Peptide 1, Glucose Dependent Insulinotropic Polypeptide, and Glucagon Receptor Agonists in Metabolic Dysfunction Associated Steatotic Liver Disease: Novel Medication in New Liver Disease Nomenclature New therapeutic agents for type 2 diabetes: anaesthetic considerations. A narrative review